Product Information
TEMAZEPAM 22.5 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $1.5492 per EA under NDC 67877014930. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 21, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
22.5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877014930
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071457FDA Approved
4/21/1987
TE Code
AB
On Market Since
6/28/2012
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 22.5 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 68.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5492 per EA |
|---|---|
| All-time high | $5.9577 (Mar 11, 2015) |
| All-time low | $1.1572 (Nov 20, 2024) |
| 52-week high | $2.0272 |
| 52-week low | $1.5147 |
| Median price | $3.2062 |
| Average price | $3.3840 |
| Largest weekly change | +81.6% (Mar 23, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
temazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 22.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 22.5 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $1.5492 per EA (NDC 67877014930), effective Sep 30, 2026.
How has the price of TEMAZEPAM 22.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has declined 68.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 22.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has ranged from a low of $1.1572 (Nov 20, 2024) to a high of $5.9577 (Mar 11, 2015), with a median of $3.2062 per EA.
Are there cheaper alternatives to TEMAZEPAM 22.5 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 22.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 22.5 MG CAPSULE?
TEMAZEPAM 22.5 MG CAPSULE (NDC 67877014930) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.